CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 12, 2012, Pages 3281-3286

  Guo, Q ^a   Li, H Y ^a   Zhou, Y P ^a   Li, M ^a   Chen, X K ^a   Liu, H ^a   Peng, H L ^a   Yu, H Q ^a   Chen, X ^a   Liu, N ^a   Liang, L H ^a   Zhao, Q Z ^a   Jiang, M ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMERICAN THORACIC SOCIETY MINOR CRITERIA; AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; COMMUNITY ACQUIRED PNEUMONIA; CONFUSION UREA RESPIRATORY RATE BLOOD PRESSURE AGE 65 SCORING SYSTEM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INFECTIOUS DISEASE SOCIETY OF AMERICA MINOR CRITERIA; INTERMETHOD COMPARISON; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84872180161     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1693-8     Document Type: Article

References (21)

1. Mandell LA, Wunderink RG, Anzueto A et al (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27-S72 (Pubitemid 46290553)
2. Guo Q, Li YM, Nong LB et al (2009) Evaluation of compliance with bundle treatment in the management of severe infection. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 21:8-12
3. Restrepo MI, Anzueto A (2009) Severe community-acquired pneumonia. Infect Dis Clin North Am 23:503-520
4. British Thoracic Society Standards of Care Committee (2001) BTS guidelines for the management of community acquired pneumonia in adults. Thorax 56(Suppl 4):IV1-IV64
5. Lim WS, Baudouin SV, George RC et al (2009) BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64(Suppl 3):iii1-iii55
6. Guo Q, Li HY, Zhou YP et al (2011) Weight of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Respir Med 105:1543-1549
7. Liapikou A, Ferrer M, Polverino E et al (2009) Severe communityacquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. Clin Infect Dis 48:377-385
8. Loke YK, Kwok CS, Niruban A et al (2010) Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis. Thorax 65:884-890
9. Falcone M, Corrao S, Venditti M et al (2011) Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia. Intern Emerg Med 6:431-436
10. Jones BE, Jones J, Bewick T et al (2011) CURB-65 pneumonia severity assessment adapted for electronic decision support. Chest 140:156-163
11. Phua J, See KC, Chan YH et al (2009) Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia. Thorax 64:598-603
12. Hilbert G, Gruson D, Vargas F et al (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481-487 (Pubitemid 32164899)
13. Niederman MS, Mandell LA, Anzueto A et al (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730-1754 (Pubitemid 32578779)
14. Dellinger RP, Carlet JM, Masur H et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858-873 (Pubitemid 38344143)
15. Aujesky D, Auble TE, Yealy DM et al (2005) Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 118:384-392 (Pubitemid 40460997)
16. Brown SM, Jones BE, Jephson AR et al (2009) Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia. Crit Care Med 37:3010-3016
17. Schuetz P, Koller M, Christ-Crain M et al (2008) Predicting mortality with pneumonia severity scores: importance of model recalibration to local settings. Epidemiol Infect 136:1628-1637
18. Lim WS, van der Eerden MM, Laing R et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377-382 (Pubitemid 36560938)
19. Niederman MS, McCombs JS, Unger AN et al (1998) The cost of treating community-acquired pneumonia. Clin Ther 20:820-837 (Pubitemid 28421502)
20. Colice GL, Morley MA, Asche C et al (2004) Treatment costs of community-acquired pneumonia in an employed population. Chest 125:2140-2145 (Pubitemid 38788182)
21. Bartolomé M, Almirall J, Morera J et al (2004) A population-based study of the costs of care for community-acquired pneumonia. Eur Respir J 23:610-616 (Pubitemid 38456006)